BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 25924874)

  • 1. Germline PRKACA amplification causes variable phenotypes that may depend on the extent of the genomic defect: molecular mechanisms and clinical presentations.
    Lodish MB; Yuan B; Levy I; Braunstein GD; Lyssikatos C; Salpea P; Szarek E; Karageorgiadis AS; Belyavskaya E; Raygada M; Faucz FR; Izzat L; Brain C; Gardner J; Quezado M; Carney JA; Lupski JR; Stratakis CA
    Eur J Endocrinol; 2015 Jun; 172(6):803-11. PubMed ID: 25924874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Germline PRKACA amplification leads to Cushing syndrome caused by 3 adrenocortical pathologic phenotypes.
    Carney JA; Lyssikatos C; Lodish MB; Stratakis CA
    Hum Pathol; 2015 Jan; 46(1):40-9. PubMed ID: 25449630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Germline PRKACA amplification-associated primary pigmented nodular adrenocortical disease: a case report and literature review.
    Yang WR; Liang XH; Qin YF; Yang HY; He SZ; Huang ZX; Liu YP; Luo ZJ
    Arch Endocrinol Metab; 2023 Nov; 68():e220491. PubMed ID: 37988664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PRKACA mutations in cortisol-producing adenomas and adrenal hyperplasia: a single-center study of 60 cases.
    Thiel A; Reis AC; Haase M; Goh G; Schott M; Willenberg HS; Scholl UI
    Eur J Endocrinol; 2015 Jun; 172(6):677-85. PubMed ID: 25750087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel somatic mutations in the catalytic subunit of the protein kinase A as a cause of adrenal Cushing's syndrome: a European multicentric study.
    Di Dalmazi G; Kisker C; Calebiro D; Mannelli M; Canu L; Arnaldi G; Quinkler M; Rayes N; Tabarin A; Laure Jullié M; Mantero F; Rubin B; Waldmann J; Bartsch DK; Pasquali R; Lohse M; Allolio B; Fassnacht M; Beuschlein F; Reincke M
    J Clin Endocrinol Metab; 2014 Oct; 99(10):E2093-100. PubMed ID: 25057884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Somatic PRKACA Mutations: Association With Transition From Pituitary-Dependent to Adrenal-Dependent Cushing Syndrome.
    Di Dalmazi G; Timmers HJLM; Arnaldi G; Küsters B; Scarpelli M; Bathon K; Calebiro D; Beuschlein F; Hermus A; Reincke M
    J Clin Endocrinol Metab; 2019 Nov; 104(11):5651-5657. PubMed ID: 31276155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mosaic PRKACA duplication causing a novel and distinct phenotype of early-onset Cushing's syndrome and acral cutaneous mucinosis.
    McGlacken-Byrne SM; Abdelmaksoud A; Haini M; Palm L; Ashworth M; Li J; Wang W; Wang X; Wang J; Callaghan B; Kinsler VA; Faravelli F; Dattani MT
    Eur J Endocrinol; 2022 Dec; 187(6):K55-K61. PubMed ID: 36691942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [New insights in adrenal Cushing syndrome].
    Haissaguerre M; Tabarin A
    Ann Endocrinol (Paris); 2014 Oct; 75 Suppl 1():S37-45. PubMed ID: 25617921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical characteristics of PRKACA mutations in Chinese patients with adrenal lesions: a single-centre study.
    Li X; Wang B; Tang L; Lang B; Zhang Y; Zhang F; Chen L; Ouyang J; Zhang X
    Clin Endocrinol (Oxf); 2016 Dec; 85(6):954-961. PubMed ID: 27296931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Constitutive activation of PKA catalytic subunit in adrenal Cushing's syndrome.
    Beuschlein F; Fassnacht M; Assié G; Calebiro D; Stratakis CA; Osswald A; Ronchi CL; Wieland T; Sbiera S; Faucz FR; Schaak K; Schmittfull A; Schwarzmayr T; Barreau O; Vezzosi D; Rizk-Rabin M; Zabel U; Szarek E; Salpea P; Forlino A; Vetro A; Zuffardi O; Kisker C; Diener S; Meitinger T; Lohse MJ; Reincke M; Bertherat J; Strom TM; Allolio B
    N Engl J Med; 2014 Mar; 370(11):1019-28. PubMed ID: 24571724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Somatic mutations of the catalytic subunit of cyclic AMP-dependent protein kinase (PRKACA) gene in Japanese patients with several adrenal adenomas secreting cortisol [Rapid Communication].
    Nakajima Y; Okamura T; Gohko T; Satoh T; Hashimoto K; Shibusawa N; Ozawa A; Ishii S; Tomaru T; Horiguchi K; Okada S; Takata D; Rokutanda N; Horiguchi J; Tsushima Y; Oyama T; Takeyoshi I; Yamada M
    Endocr J; 2014; 61(8):825-32. PubMed ID: 25069672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathological correlates of adrenal Cushing's syndrome.
    Duan K; Gomez Hernandez K; Mete O
    J Clin Pathol; 2015 Mar; 68(3):175-86. PubMed ID: 25425660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein kinase A defects and cortisol-producing adrenal tumors.
    Zilbermint M; Stratakis CA
    Curr Opin Endocrinol Diabetes Obes; 2015 Jun; 22(3):157-62. PubMed ID: 25871963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PRKACA: the catalytic subunit of protein kinase A and adrenocortical tumors.
    Berthon AS; Szarek E; Stratakis CA
    Front Cell Dev Biol; 2015; 3():26. PubMed ID: 26042218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carney complex: an update.
    Correa R; Salpea P; Stratakis CA
    Eur J Endocrinol; 2015 Oct; 173(4):M85-97. PubMed ID: 26130139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PRKAR1A-negative familial Cushing's syndrome: two case reports.
    Lim LL; Kitan N; Paramasivam SS; Ratnasingam J; Ibrahim L; Chan SP; Tan AT; Vethakkan SR
    J Med Case Rep; 2015 Dec; 9():277. PubMed ID: 26619967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Familial adrenocorticotropin-independent Cushing's syndrome with bilateral macronodular adrenal hyperplasia.
    Findlay JC; Sheeler LR; Engeland WC; Aron DC
    J Clin Endocrinol Metab; 1993 Jan; 76(1):189-91. PubMed ID: 8380604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recurrent somatic mutations underlie corticotropin-independent Cushing's syndrome.
    Sato Y; Maekawa S; Ishii R; Sanada M; Morikawa T; Shiraishi Y; Yoshida K; Nagata Y; Sato-Otsubo A; Yoshizato T; Suzuki H; Shiozawa Y; Kataoka K; Kon A; Aoki K; Chiba K; Tanaka H; Kume H; Miyano S; Fukayama M; Nureki O; Homma Y; Ogawa S
    Science; 2014 May; 344(6186):917-20. PubMed ID: 24855271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PRKACA Somatic Mutations Are Rare Findings in Aldosterone-Producing Adenomas.
    Rhayem Y; Perez-Rivas LG; Dietz A; Bathon K; Gebhard C; Riester A; Mauracher B; Gomez-Sanchez C; Eisenhofer G; Schwarzmayr T; Calebiro D; Strom TM; Reincke M; Beuschlein F
    J Clin Endocrinol Metab; 2016 Aug; 101(8):3010-7. PubMed ID: 27270477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activating hotspot L205R mutation in PRKACA and adrenal Cushing's syndrome.
    Cao Y; He M; Gao Z; Peng Y; Li Y; Li L; Zhou W; Li X; Zhong X; Lei Y; Su T; Wang H; Jiang Y; Yang L; Wei W; Yang X; Jiang X; Liu L; He J; Ye J; Wei Q; Li Y; Wang W; Wang J; Ning G
    Science; 2014 May; 344(6186):913-7. PubMed ID: 24700472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.